Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.30 HKD
−103.88 M HKD
256.74 M HKD
13.22 M
About SHANGHAI HEARTCARE MEDICAL TECHNOLO
Sector
Industry
CEO
Guo Hui Wang
Website
Headquarters
Shanghai
Founded
2016
ISIN
CNE100004MN5
FIGI
BBG01231S8S0
Shanghai Heartcare Medical Technology Corp. Ltd. engages in the research, development, manufacture, and sale of neuro-interventional medical devices. Its objective is to redefine the therapeutic and preventive paradigm of stroke. The company was founded by Guo Hui Wang, Kui Ding, and Jia Qi Hong on June 16, 2016 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6609 is 23.95 HKD — it has increased by 3.46% in the past 24 hours. Watch SHANGHAI HEARTCARE MEDICAL TECHNOLO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANGHAI HEARTCARE MEDICAL TECHNOLO stocks are traded under the ticker 6609.
6609 stock has risen by 0.63% compared to the previous week, the month change is a 19.45% rise, over the last year SHANGHAI HEARTCARE MEDICAL TECHNOLO has showed a 0.42% increase.
6609 reached its all-time high on Sep 9, 2021 with the price of 147.50 HKD, and its all-time low was 12.10 HKD and was reached on Aug 26, 2024. View more price dynamics on 6609 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6609 stock is 4.36% volatile and has beta coefficient of 1.47. Track SHANGHAI HEARTCARE MEDICAL TECHNOLO stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI HEARTCARE MEDICAL TECHNOLO there?
Today SHANGHAI HEARTCARE MEDICAL TECHNOLO has the market capitalization of 927.73 M, it has decreased by −1.07% over the last week.
Yes, you can track SHANGHAI HEARTCARE MEDICAL TECHNOLO financials in yearly and quarterly reports right on TradingView.
SHANGHAI HEARTCARE MEDICAL TECHNOLO is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
6609 earnings for the last half-year are −0.15 HKD per share, whereas the estimation was −0.18 HKD, resulting in a 17.65% surprise. The estimated earnings for the next half-year are −0.23 HKD per share. See more details about SHANGHAI HEARTCARE MEDICAL TECHNOLO earnings.
SHANGHAI HEARTCARE MEDICAL TECHNOLO revenue for the last half-year amounts to 138.05 M HKD, despite the estimated figure of 156.12 M HKD. In the next half-year revenue is expected to reach 200.46 M HKD.
6609 net income for the last half-year is −5.55 M HKD, while the previous report showed −42.86 M HKD of net income which accounts for 87.06% change. Track more SHANGHAI HEARTCARE MEDICAL TECHNOLO financial stats to get the full picture.
No, 6609 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 368.00 employees. See our rating of the largest employees — is SHANGHAI HEARTCARE MEDICAL TECHNOLO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI HEARTCARE MEDICAL TECHNOLO EBITDA is −28.87 M HKD, and current EBITDA margin is −40.71%. See more stats in SHANGHAI HEARTCARE MEDICAL TECHNOLO financial statements.
Like other stocks, 6609 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI HEARTCARE MEDICAL TECHNOLO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI HEARTCARE MEDICAL TECHNOLO technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI HEARTCARE MEDICAL TECHNOLO stock shows the buy signal. See more of SHANGHAI HEARTCARE MEDICAL TECHNOLO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.